Novo Nordisk (NVO) OPEX US GAAP (year values) |
|||||||||
2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
OPEX | 58 498 000 000 | 58 498 000 000 | 73 697 000 000 | 73 697 000 000 | 93 922 000 000 | 106 464 000 000 | |||
Changes by years, y/y, % | +13% | 0% | +26% | 0% | +27% | +14.9% |
Novo Nordisk. OPEX
Novo Nordisk. OPEX, changes, %
Novo Nordisk. OPEX, sum by quarters
Novo Nordisk (NVO) OPEX US GAAP (quarter values) |
||||||||
2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
OPEX | 22 556 000 000 | 22 105 000 000 | 29 083 000 000 | 23 019 000 000 | 32 257 000 000 | 106 464 000 000 | ||
Changes by years, y/y, % | +34% | +22% | +28% | +14% | +43% | |||
Changes by quarters, q/q, % | -2% | +32% | -21% | +40% |